Particle.news
Download on the App Store

Spain Expands RSV Vaccination to High-Risk Adults as Argentina Sets Jan. 12 Start for Maternal Campaign

The moves aim to protect vulnerable groups ahead of peak transmission, reducing hospital pressure.

Overview

  • Spain’s health council approved 2026 guidance to vaccinate residents aged 60 and older in care homes and adults 18+ with defined immunosuppressive conditions.
  • The Spanish rollout will phase in from 2026 with completion by autumn 2028, using a single autumn dose that may be coadministered with flu, COVID-19 or pneumococcal vaccines.
  • Spain’s plan requires seasonal epidemiological and genetic RSV surveillance to fine-tune strategy and detect variants that could affect effectiveness.
  • Argentina confirmed a synchronized national start on January 12, 2026 for maternal RSV vaccination, with doses already in-country and distribution to provinces beginning next week.
  • Argentina will vaccinate pregnant people at 32–36+6 weeks without a doctor’s order, building on 2025 results showing a 62% drop in infant hospitalizations and 70% fewer ICU admissions.